The expression of P-glycoprotein and cellular kinases is modulated at the transcriptional level by infection and highly in a primate active antiretroviral therapy model of AIDS

被引:11
作者
Jorajuria, S
Clayette, P
Dereuddre-Bosquet, N
Benlhassan-Chahour, K
Thiébot, H
Vaslin, B
Le Grand, R
Dormont, D
机构
[1] CEA, DSV DRM, Serv Neurovirol, SPIBIO, F-92265 Fontenay Aux Roses, France
[2] IPSC, EPHE, DRM DSV,Serv Virol, CEA, F-92265 Fontenay Aux Roses, France
关键词
D O I
10.1089/088922203764969500
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The beneficial effects of highly active antiretroviral therapy (HAART) in HIV-infected patients may be limited by inadequate compliance and viral resistance, but also by host cell factors, such as P-glycoprotein (P-gp) and intracellular kinases involved in the phosphorylation of nucleoside reverse transcriptase inhibitors. We investigated the effects of infection and HAART (zidovudine [AZT], lamivudine [3TC], and indinavir [IDV] on the expression of P-gp and cell kinases involved in the phosphorylation of AZT and 3TC in SHIV89.6P-infected cynomolgus; macaques. Under unstimulated conditions, we observed a decrease in P-gp mRNA levels in the peripheral blood and lymph node mononuclear cells of infected macaques, which was accentuated by HAART. SHIV infection also resulted in the overexpression of thymidine kinase mRNA, which was abolished by HAART. In conclusion, retroviral infection and HAART modulate in vivo at the transcriptional level the expression of host cell factors that may affect the efficacy of HAART.
引用
收藏
页码:307 / 311
页数:5
相关论文
共 25 条
[1]   Abnormal expression of a 170-kilodalton P-glycoprotein encoded by MDR1 gene, a metabolically active efflux pump, in CD4(+) and CD8(+) T cells from patients with human immunodeficiency virus type 1 infection [J].
Andreana, A ;
Aggarwal, S ;
Gollapudi, S ;
Wien, D ;
Tsuruo, T ;
Gupta, S .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1996, 12 (15) :1457-1462
[2]   Long-term exposure to zidovudine affects in vitro and in vivo the efficiency of phosphorylation of thymidine kinase [J].
Antonelli, G ;
Turriziani, O ;
Verri, A ;
Narciso, P ;
Ferri, F ;
DOffizi, G ;
Dianzani, F .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1996, 12 (03) :223-228
[3]   ZIDOVUDINE PHOSPHORYLATION IN HIV-INFECTED PATIENTS AND SERONEGATIVE VOLUNTEERS [J].
BARRY, M ;
WILD, M ;
VEAL, G ;
BACK, D ;
BRECKENRIDGE, A ;
FOX, R ;
BEECHING, N ;
NYE, F ;
CAREY, P ;
TIMMINS, D .
AIDS, 1994, 8 (08) :F1-F5
[4]  
Benveniste O, 1998, CYTOKINES CELL MOL T, V4, P207
[5]   Significance of P-glycoprotein for the pharmacology and clinical use of HIV protease inhibitors [J].
Clayette, P ;
Jorajuria, S ;
Dormont, D .
AIDS, 2000, 14 (03) :235-236
[6]   Zidovudine (AZT) resistance in H9 cells due to decreased TK expression is associated with hypermethylation of TK gene [J].
Gröschel, B ;
Höver, G ;
Doerr, HW ;
Cinatl, J .
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2001, 20 (4-7) :487-492
[7]  
Günthard HF, 1998, J VIROL, V72, P2422
[8]   Effect of protease inhibitors on nucleoside analogue phosphorylation in vitro [J].
Hoggard, PG ;
Manion, V ;
Barry, MG ;
Back, DJ .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 45 (02) :164-167
[9]   DECREASED THYMIDINE KINASE LEVELS IN PERIPHERAL-BLOOD CELLS FROM HIV-SEROPOSITIVE INDIVIDUALS - IMPLICATIONS FOR ZIDOVUDINE METABOLISM [J].
JACOBSSON, B ;
BRITTON, S ;
HE, QM ;
KARLSSON, A ;
ERIKSSON, S .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1995, 11 (07) :805-811
[10]   The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors [J].
Kim, RB ;
Fromm, MF ;
Wandel, C ;
Leake, B ;
Wood, AJJ ;
Roden, DM ;
Wilkinson, GR .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (02) :289-294